Latest1 information on COVID-19
©2022 Stanford Medicine
Trial ID: NCT01165775
Continuous Glucose Monitoring in Pregnant Women Undergoing Betamethasone Therapy
Charles B. and Ann L. Johnson Professor in the School of Medicine and Professor, by courtesy, of Pediatrics (Neonatology) and of Surgery
Inclusion Criteria:- 18 years of age or older
- Receiving betamethasone as part of routine clinical care.
- Pregnancy between 23+5 and 35+0 weeks Exclusion Criteria:- Less than 18 years old.
- Major fetal anomalies
- Use of steroid medications in the past 2 weeks.
device: Dexcom Seven Plus Continuous Glucose Monitoring System
School of Medicine
300 Pasteur Drive
Stanford, CA 94305